Anastrozole Tablets Market - Restraints
However, anastrozole tablets market growth is expected to hamper over the forecast period, owing to frequent drug recalls. For instance, in May 2019, Zydus Pharmaceuticals USA Inc. announced that it voluntarily recalled multiple lots of anastrozole tablets (1mg) at retail level. The product is under investigation by the U.S. FDA. The reason of drug recall was cross contamination due to a GMP cleaning procedure failure in the fluid bed dry processor area during the manufacturing time. Zydus Pharmaceuticals USA Inc. advised all the distributors to stop dispensing, which rapidly impeded growth of the anastrozole tablets market in 2019.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients